A roadmap for clinical trial design in marginal zone lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26706
Abstract: Significant advances in the drug development of indolent non-Hodg-kin lymphoma (iNHL) occurred over the last years expanding the landscape of treatment options. Several novel agents have been approved by the US Food and Drug Administration… read more here.
Keywords: lymphoma; design marginal; roadmap clinical; clinical trial ... See more keywords